source
- SonoThera secures $125 million to advance ultrasound-based gene therapy for Duchenne and polycystic kidney diseaseSonoThera announced it has raised $125 million in financing to move its ultrasound-based non-viral gene therapy platform toward clinical testing. The funding will support the company’s two lead pr…
- Shattuck Labs raises $75M in public offering, selling 10.5M shares at $4 eachShattuck Labs announced a $75 million public offering to raise capital. The company is selling more than 10.5 million shares at $4 per share and is also issuing pre‑funded warrants to selected inv…